NEURODEGENERATIVE DISEASE TREATMENT DRUG PBT2 BREAKS INTRINSIC POLYMYXIN RESISTANCE IN GRAM-POSITIVE BACTERIA

Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria

Gram-positive bacteria do not produce lipopolysaccharide as a cell wall component.As such, the Soap polymyxin class of antibiotics, which exert bactericidal activity against Gram-negative pathogens, are ineffective against Gram-positive bacteria.The safe-for-human-use hydroxyquinoline analog ionophore PBT2 has been previously shown to break polymyx

read more

Robust Tracking with Discriminative Ranking Middle-Level Patches

The appearance model has been shown to be essential for robust visual tracking since it is the basic criterion to locating targets in video sequences.Though existing tracking-by-detection algorithms have shown to be greatly promising, they still Soap suffer from the drift problem, which is caused by updating appearance models.In this paper, we prop

read more



Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir

Cytomegalovirus (CMV) infection is widespread in the general population.In patients with severe and/or steroid-refractory ulcerative colitis (UC), local reactivation of CMV can be detected in actively Mug inflamed colonic tissue in approximately 30% of cases.However, the role of CMV in patients with UC is not clearly understood.There is evidence to

read more